adinazolam has been researched along with Panic Disorder in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 5 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Carter, CS; Denahan, AQ; Fawcett, J; Hertzman, M; Jones, W; Maddock, RJ; Papp, LA; Patterson, WM; Swinson, RP; Weise, CC | 1 |
Beitman, B; Carter, C; Davidson, JR; Greist, JH; Haack, DG; Krishnan, KR; Lewis, CP; Liebowitz, MR; Maddock, RJ; Sheridan, AQ | 1 |
Carter, CS; Gietzen, DW; Maddock, RJ; Magliozzi, JR | 1 |
Beitman, BD; Blacker, KH; Carter, CS; Jefferson, JW; Krishnan, KR; Lewis, CP; Liebowitz, MR; Maddock, RJ | 1 |
Beck, NC; Beitman, BD; Carter, CS; Davidson, JR; Deuser, WE; Maddock, RJ | 1 |
5 trial(s) available for adinazolam and Panic Disorder
Article | Year |
---|---|
Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.
Topics: Adolescent; Adult; Aged; Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome | 1995 |
Adinazolam sustained-release treatment of panic disorder: a double-blind study.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Panic Disorder; Personality Assessment; Personality Inventory; Psychometrics; Treatment Outcome | 1994 |
Evidence that decreased function of lymphocyte beta adrenoreceptors reflects regulatory and adaptive processes in panic disorder with agoraphobia.
Topics: Adult; Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Cyclic AMP; Double-Blind Method; Down-Regulation; Female; Humans; Isoproterenol; Lymphocytes; Male; Panic Disorder; Placebos; Receptors, Adrenergic, beta | 1993 |
Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia.
Topics: Adult; Aged; Agoraphobia; Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Comorbidity; Depressive Disorder; Female; Humans; Male; Middle Aged; Panic Disorder; Prognosis; Psychiatric Status Rating Scales; Recurrence; Severity of Illness Index; Treatment Outcome | 1993 |
Patient Stage of Change predicts outcome in a panic disorder medication trial.
Topics: Agoraphobia; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Humans; Male; Motivation; Panic Disorder; Patient Acceptance of Health Care; Personality Inventory; Treatment Outcome | 1994 |